Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

BI and University of Dundee ink collaboration for PROTACs

Executive Summary

Boehringer Ingelheim GMBH and the University of Dundee entered into a collaboration to develop proteolysis targeting chimeric molecules (PROTACs), which are a novel class of medicines that target disease-causing protein degradation.

Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D (No Licensing)

Related Companies

UsernamePublicRestriction

Register